Cartesian Therapeutics (RNAC) Asset Utilization Ratio (2016 - 2026)
Cartesian Therapeutics' (RNAC) Asset Utilization Ratio came in at 0.00 for Q2 2026, up 89.3% from 0.00 a year earlier but down 19.8% from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
For FY2025, Cartesian Therapeutics' Asset Utilization Ratio stood at 0.01, down 92.7% from FY2024.
- Annual Asset Utilization Ratio has declined for three consecutive years.
- In prior years, Cartesian Therapeutics' Asset Utilization Ratio was 0.11 in FY2024 (-4.8%), 0.11 in FY2023 (-83.8%), 0.68 in FY2022 (+30.0%) and 0.52 in FY2021 (+317.6%).
- Quarterly Asset Utilization Ratio has run from a low of 0.00 in Q2 2025 to a high of 0.76 in Q2 2022 over five years.
- On a year-over-year basis, Asset Utilization Ratio increased in 1 of the last eight quarters, with an average decline of 47.5%.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q4 2021, with growth of 443.0%; the weakest was Q2 2025, with a decline of 98.4%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.01 (Q1 2026), 0.01 (Q4 2025) and 0.00 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 0.13 |
| Sep 30, 2023 | 0.28 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.51 |
| Dec 31, 2022 | 0.64 |
| Sep 30, 2022 | 0.68 |
| Jun 30, 2022 | 0.76 |
| Mar 31, 2022 | 0.71 |
| Dec 31, 2021 | 0.52 |
| Sep 30, 2021 | 0.39 |
API Access
Cartesian Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();